This is a Validated Antibody Database (VAD) review about pigs , based on 53 published articles (read how Labome selects the articles), using ACTA2 antibody in all methods. It is aimed to help Labome visitors find the most suited ACTA2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ACTA2 synonym: ACT-4; actin

Invitrogen
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3c
Invitrogen ACTA2 antibody (Neomarkers, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3c). Biochem Biophys Rep (2022) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5a, 5b, 5c
Invitrogen ACTA2 antibody (Thermo Fisher, 1A4) was used in immunohistochemistry - frozen section on mouse samples (fig 5a, 5b, 5c). PLoS ONE (2022) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; loading ...
Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11869) was used in western blot on human samples . PLoS ONE (2020) ncbi
mouse monoclonal (1A4)
  • immunocytochemistry; human; loading ...; fig 2b
Invitrogen ACTA2 antibody (eBioscience, 1A4) was used in immunocytochemistry on human samples (fig 2b). BMC Cancer (2020) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:2000; loading ...; fig 1b
Invitrogen ACTA2 antibody (ThermoFisher, MA5-11869) was used in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2019) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:4000; loading ...; fig 1b
Invitrogen ACTA2 antibody (Thermo fisher, MA5-11869) was used in western blot on human samples at 1:4000 (fig 1b). Nature (2019) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:50; loading ...; fig 2d
Invitrogen ACTA2 antibody (Thermo, MA5-11869) was used in western blot on human samples at 1:50 (fig 2d). Nat Commun (2018) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:1000; loading ...; fig 2e
In order to study the involvement of RNase III nucleases in antiviral systems, Invitrogen ACTA2 antibody (Thermo Fisher, MS-1295-P) was used in western blot on human samples at 1:1000 (fig 2e). Nature (2017) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; loading ...; fig 11a
In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, 1A4) was used in immunohistochemistry on human samples (fig 11a). Front Immunol (2017) ncbi
mouse monoclonal (1A4)
  • western blot; human; fig 3e
In order to test if exogenous transfer of unphosphorylated phosphatase and tensin homologue deleted from chromosome 10 leads to reduce transforming growth factor beta-induced extracellular matrix expression in both epithelial cells and fibroblasts, Invitrogen ACTA2 antibody (Lab Vision, 1A4) was used in western blot on human samples (fig 3e). Wound Repair Regen (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; zebrafish ; 1:5000; loading ...; fig s2e
In order to propose that neurodevelopmental disorders and brain tumors may arise from changes in oncogenes, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on zebrafish samples at 1:5000 (fig s2e). Dis Model Mech (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:100; loading ...; fig 1b
In order to find that TrpC5 regulates differentiation in colorectal cancer, Invitrogen ACTA2 antibody (Invitrogen, MA5-11869) was used in western blot on human samples at 1:100 (fig 1b). Clin Sci (Lond) (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; loading ...; fig 5g
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 5g). J Cell Physiol (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:300; fig 2
In order to study CD133+ subpopulations in pancreatic cancer, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, Ab-5) was used in western blot on human samples at 1:300 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
In order to characterize alterations in fibroblast populations in the skin of patients with systemic sclerosis, Invitrogen ACTA2 antibody (Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples (fig 3b). Am J Pathol (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 1
In order to study how PARylation regulates Top1 nuclear dynamics, Invitrogen ACTA2 antibody (Neo Markers, ACTN05) was used in western blot on human samples (fig 1). Nucleic Acids Res (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 3b
In order to screen for deubiquitinase inhibitors that prevent infection of macrophages by intracellular pathogens, Invitrogen ACTA2 antibody (Thermo Scientific, ACTN05) was used in western blot on mouse samples (fig 3b). Antimicrob Agents Chemother (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:3000; fig 3
  • western blot; mouse; 1:3000; fig 1
In order to investigate the PTHrP-cAMP-CREB1 axis in osteosarcoma, Invitrogen ACTA2 antibody (Thermo Scientific, Ab-5) was used in western blot on human samples at 1:3000 (fig 3) and in western blot on mouse samples at 1:3000 (fig 1). elife (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 1
In order to study attenuation of AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC by the human papillomavirus 16 E7 oncoprotein, Invitrogen ACTA2 antibody (Thermo Scientific, MS-1295-P1) was used in western blot on human samples (fig 1). J Virol (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; dogs; fig 8
In order to study how the role of increased caveolin-1 can help with repair to intervertebral disc degeneration, Invitrogen ACTA2 antibody (Neomarkers, pan Ab-5) was used in western blot on dogs samples (fig 8). Arthritis Res Ther (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; fig 2
In order to study human lacrimal epithelium and histatin-1 expression, Invitrogen ACTA2 antibody (Thermo Scientific, MS-113-P0) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:10,000; fig 3
In order to investigate how redox reactions affect treatment of chronic lymphocytic leukemia, Invitrogen ACTA2 antibody (Pierce Biotechnology, MA5-11869) was used in western blot on human samples at 1:10,000 (fig 3). Mol Med Rep (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; 1:1000; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Invitrogen ACTA2 antibody (NeoMarkers, 1A4) was used in immunohistochemistry on human samples at 1:1000 (fig 6). Diagn Pathol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; fruit fly ; 1:4000; fig 9
In order to suggest that CDK8-CycC links nutrient intake to EcR activity and Drosophila development, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869)) was used in western blot on fruit fly samples at 1:4000 (fig 9). PLoS Biol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:500; fig 5a
In order to assess the anti-fatigue effects of Myelophil, Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11869) was used in western blot on mouse samples at 1:500 (fig 5a). Eur J Pharmacol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to discuss using serum CSE1L as a biomarker for assessing the efficacy of cancer therapy, Invitrogen ACTA2 antibody (Lab Vision, Ab-5) was used in western blot on human samples . J Transl Med (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; rat; 1:5000
In order to study the epithelial and stromal alterations in prostate following cypermethrin administration in adult albino rats, Invitrogen ACTA2 antibody (Lab Vision Corporation, alpha-Actin) was used in immunohistochemistry - paraffin section on rat samples at 1:5000. Tissue Cell (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:500
In order to evaluate the anti-fatigue effects of Gongjin-Dan in a chronic forced exercise mouse model, Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11869) was used in western blot on mouse samples at 1:500. J Ethnopharmacol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse
In order to evaluate the protective effect of dietary cis9, trans11 conjugated linoleic acid on gliadin-induced enteropathy, Invitrogen ACTA2 antibody (Thermo Scientific, ACTN05) was used in western blot on mouse samples . Eur J Nutr (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; 1:300
In order to identify and characterize vessels that encapsulated tumor clusters in hepatocellular carcinoma sections, Invitrogen ACTA2 antibody (Life Technologies, 1A4) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hepatology (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; rat; 1:200
In order to investigate the role of cannabinoid receptor type 2 (CB2R) during skeletal muscle regeneration, Invitrogen ACTA2 antibody (Lab Vision, MS-113) was used in immunohistochemistry - paraffin section on rat samples at 1:200. Histol Histopathol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:10,000; fig 5
In order to show that sustained Zeb2 expression initiates T-cell leukemia, Invitrogen ACTA2 antibody (Molecular probes, C4) was used in western blot on human samples at 1:10,000 (fig 5). Nat Commun (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 1,2,3,4,5,6
In order to determine the role of progesterone receptor activation in increasing protein turnover and downregulation of GATA3 transcriptional repression which promotes breast tumor growth, Invitrogen ACTA2 antibody (neomarkers, ACTN05) was used in western blot on mouse samples (fig 1,2,3,4,5,6). Breast Cancer Res (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to examine the effects of miR-23a in cell death, Invitrogen ACTA2 antibody (NeoMarkers, ACTN05) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (1A4)
In order to examine the adverse effect of prostaglandin F-receptor antagonist AS604872 on brain vasculature, Invitrogen ACTA2 antibody (Thermo Scientific, MS113) was used . J Pharmacol Sci (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; 1:600
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen ACTA2 antibody (LabVision, 1A4) was used in immunohistochemistry on human samples at 1:600. Arch Dermatol Res (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
In order to characterize PDGF-mediated skeletal muscle angiogenesis and the role of CD248 (Endosialin), Invitrogen ACTA2 antibody (NeoMarkers, 1A4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; fruit fly ; 1:4000
In order to study the role of Histone lysine demethylase 2 (KDM2) in Drosophila development, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869) was used in western blot on fruit fly samples at 1:4000. Mech Dev (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; dogs; 1:2000
In order to analyze divergent LEF1 expression in ligand-independent canonical Wnt activity in canine mammary tumor cell lines, Invitrogen ACTA2 antibody (Thermo, MS-1295-P1) was used in western blot on dogs samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (ACTN05 (C4))
In order to investigate the role of Wdr1 in actin dynamics, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, MS-1295-P1ABX) was used . Am J Pathol (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen ACTA2 antibody (Fisher/Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:1000; fig 5
In order to investigate the relationship between vitamin D and parathyroid hormone signaling during skeletal development, Invitrogen ACTA2 antibody (NeoMarkers, MS-1295-P1) was used in western blot on mouse samples at 1:1000 (fig 5). J Cell Physiol (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 1
In order to investigate the role of caspase-2 in programed cell death during infection with Brucella abortus, Invitrogen ACTA2 antibody (Thermo Scientific, MS1295P1) was used in western blot on mouse samples (fig 1). Front Cell Infect Microbiol (2013) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse
In order to test if enterically targeted rapamycin prevents neoplasia and extends survival of cancer prone Apc(Min/+) mice, Invitrogen ACTA2 antibody (Thermo Fisher, ACTN05) was used in western blot on mouse samples . Cancer Prev Res (Phila) (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; mouse
In order to study the induction of inflammation, metaplasia and displasia following transgenic expression of IFN-gamma in the murine stomach, Invitrogen ACTA2 antibody (NeoMarkers, MS-113-P0) was used in immunohistochemistry on mouse samples . Am J Pathol (2012) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 3
In order to report that CSE1L regulates the association of alpha-tubulin with beta-tubulin and promotes migration of MCF-7 breast cancer cells, Invitrogen ACTA2 antibody (Lab Vision, Ab-5) was used in western blot on human samples (fig 3). Exp Cell Res (2010) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 6
In order to characterize a mouse model of endocrine-resistant breast cancer, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on mouse samples (fig 6). PLoS ONE (2010) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 8
In order to report on two cases of classic and desmoplastic medulloblastoma and the characterization of two new cell lines, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 8). Neuropathology (2009) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 4
In order to ascertain the role of epithelial cadherin in gamete interaction, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 4). Mol Hum Reprod (2008) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; pigs ; fig 3
  • immunohistochemistry; human
In order to investigate the effect of PEGDA hydrogel on the production of extracellular matrix from vocal fold fibroblasts, Invitrogen ACTA2 antibody (LabVision, 1A4) was used in immunohistochemistry on pigs samples (fig 3) and in immunohistochemistry on human samples . Acta Biomater (2008) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:1000
  • western blot; rat; 1:1000
In order to compare hippocampi from temporal lobe epilepsy patients with those from non-epileptic patients, Invitrogen ACTA2 antibody (LabVision, ACTN05) was used in western blot on human samples at 1:1000 and in western blot on rat samples at 1:1000. Brain (2007) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; mouse; 0.34 ug/ml
In order to report that disruption of the mouse Par3 gene results in midgestational embryonic lethality with defective epicardial development, Invitrogen ACTA2 antibody (Zymed, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 0.34 ug/ml. Development (2006) ncbi
Articles Reviewed
  1. Murata S, Yamanaka M, Taniguchi W, Kajioka D, Suzuki K, Yamada G, et al. Lack of transient receptor potential ankyrin 1 (TRPA1) retards cutaneous wound healing in mice: A preliminary study. Biochem Biophys Rep. 2022;31:101322 pubmed publisher
  2. Huang C, Schuring J, Skinner J, Mok L, Chong M. MYL9 deficiency is neonatal lethal in mice due to abnormalities in the lung and the muscularis propria of the bladder and intestine. PLoS ONE. 2022;17:e0270820 pubmed publisher
  3. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  4. Ortiz Otero N, Marshall J, Lash B, King M. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873 pubmed publisher
  5. Fons N, Sundaram R, Breuer G, Peng S, McLean R, Kalathil A, et al. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nat Commun. 2019;10:3790 pubmed publisher
  6. Zhao B, Du F, Xu P, Shu C, Sankaran B, Bell S, et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature. 2019;: pubmed publisher
  7. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed publisher
  8. Aguado L, Schmid S, May J, Sabin L, Panis M, Blanco Melo D, et al. RNase III nucleases from diverse kingdoms serve as antiviral effectors. Nature. 2017;547:114-117 pubmed publisher
  9. Garcia Hernandez M, Uribe Uribe N, Espinosa González R, Kast W, Khader S, Rangel Moreno J. A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression. Front Immunol. 2017;8:563 pubmed publisher
  10. Kimura M, Hashimoto N, Kusunose M, Aoyama D, Sakamoto K, Miyazaki S, et al. Exogenous induction of unphosphorylated PTEN reduces TGFβ-induced extracellular matrix expressions in lung fibroblasts. Wound Repair Regen. 2017;25:86-97 pubmed publisher
  11. Mayrhofer M, Gourain V, Reischl M, Affaticati P, Jenett A, Joly J, et al. A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth. Dis Model Mech. 2017;10:15-28 pubmed publisher
  12. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed publisher
  13. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  14. Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L, et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817 pubmed
  15. Nazari B, Rice L, Stifano G, Barron A, Wang Y, Korndorf T, et al. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Am J Pathol. 2016;186:2650-64 pubmed publisher
  16. Das S, Rehman I, Ghosh A, Sengupta S, Majumdar P, Jana B, et al. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells. Nucleic Acids Res. 2016;44:8363-75 pubmed publisher
  17. Passalacqua K, Charbonneau M, Donato N, Showalter H, Sun D, Wen B, et al. Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Antimicrob Agents Chemother. 2016;60:4183-96 pubmed publisher
  18. Walia M, Ho P, Taylor S, Ng A, Gupte A, Chalk A, et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. elife. 2016;5: pubmed publisher
  19. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed publisher
  20. Bach F, Zhang Y, Miranda Bedate A, Verdonschot L, Bergknut N, Creemers L, et al. Increased caveolin-1 in intervertebral disc degeneration facilitates repair. Arthritis Res Ther. 2016;18:59 pubmed publisher
  21. Shah D, Ali M, Pasha Z, Jaboori A, Jassim S, Jain S, et al. Histatin-1 Expression in Human Lacrimal Epithelium. PLoS ONE. 2016;11:e0148018 pubmed publisher
  22. Zhang W, Pelicano H, Yin R, Zeng J, Wen T, Ding L, et al. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Mol Med Rep. 2015;12:7374-88 pubmed publisher
  23. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed publisher
  24. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
  25. Xie X, Hsu F, Gao X, Xu W, Ni J, Xing Y, et al. CDK8-Cyclin C Mediates Nutritional Regulation of Developmental Transitions through the Ecdysone Receptor in Drosophila. PLoS Biol. 2015;13:e1002207 pubmed publisher
  26. Lee J, Kim H, Han J, Kim Y, Son C. Anti-fatigue effect of Myelophil in a chronic forced exercise mouse model. Eur J Pharmacol. 2015;764:100-8 pubmed publisher
  27. Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, et al. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. J Transl Med. 2015;13:191 pubmed publisher
  28. Hashem H, Abd El Haleem M, Abass M. Epithelial and stromal alterations in prostate after cypermethrin administration in adult albino rats (histological and biochemical study). Tissue Cell. 2015;47:366-72 pubmed publisher
  29. Hong S, Lee J, Lee J, Lee H, Kim H, Lee S, et al. The traditional drug Gongjin-Dan ameliorates chronic fatigue in a forced-stress mouse exercise model. J Ethnopharmacol. 2015;168:268-78 pubmed publisher
  30. Bergamo P, Palmieri G, Cocca E, Ferrandino I, Gogliettino M, Monaco A, et al. Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice. Eur J Nutr. 2016;55:729-740 pubmed publisher
  31. Fang J, Zhou H, Zhang C, Shang L, Zhang L, Xu J, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62:452-65 pubmed publisher
  32. Yu T, Wang X, Zhao R, Zheng J, Li L, Ma W, et al. Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle post-contusion. Histol Histopathol. 2015;30:737-49 pubmed publisher
  33. Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794 pubmed publisher
  34. Izzo F, Mercogliano F, Venturutti L, Tkach M, Inurrigarro G, Schillaci R, et al. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Res. 2014;16:491 pubmed publisher
  35. Roufayel R, Johnston D, Mosser D. The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70. Cell Death Dis. 2014;5:e1546 pubmed publisher
  36. Fukuda M, Aoki T, Manabe T, Maekawa A, Shirakawa T, Kataoka H, et al. Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872. J Pharmacol Sci. 2014;126:230-42 pubmed
  37. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  38. Naylor A, McGettrick H, Maynard W, May P, Barone F, Croft A, et al. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis. PLoS ONE. 2014;9:e107146 pubmed publisher
  39. Zheng Y, Hsu F, Xu W, Xie X, Ren X, Gao X, et al. A developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster. Mech Dev. 2014;133:36-53 pubmed publisher
  40. Gracanin A, Timmermans Sprang E, van Wolferen M, Rao N, Grizelj J, Vince S, et al. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression. PLoS ONE. 2014;9:e98698 pubmed publisher
  41. Yuan B, Wan P, Chu D, Nie J, Cao Y, Luo W, et al. A cardiomyocyte-specific Wdr1 knockout demonstrates essential functional roles for actin disassembly during myocardial growth and maintenance in mice. Am J Pathol. 2014;184:1967-80 pubmed publisher
  42. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  43. Bach F, Rutten K, Hendriks K, Riemers F, Cornelissen P, de Bruin A, et al. The paracrine feedback loop between vitamin D? (1,25(OH)?D?) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol. 2014;229:1999-2014 pubmed publisher
  44. Bronner D, O Riordan M, He Y. Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis. Front Cell Infect Microbiol. 2013;3:83 pubmed publisher
  45. Hasty P, Livi C, Dodds S, Jones D, Strong R, Javors M, et al. eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res (Phila). 2014;7:169-78 pubmed publisher
  46. Syu L, El Zaatari M, Eaton K, Liu Z, Tetarbe M, Keeley T, et al. Transgenic expression of interferon-? in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol. 2012;181:2114-25 pubmed publisher
  47. Tai C, Shen S, Lee W, Liao C, Deng W, Chiou H, et al. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res. 2010;316:2969-81 pubmed publisher
  48. Polo M, Arnoni M, Riggio M, Wargon V, Lanari C, Novaro V. Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice. PLoS ONE. 2010;5:e10786 pubmed publisher
  49. Holthouse D, Dallas P, Ford J, Fabian V, Murch A, Watson M, et al. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines. Neuropathology. 2009;29:398-409 pubmed publisher
  50. Marín Briggiler C, Veiga M, Matos M, Echeverría M, Furlong L, Vazquez Levin M. Expression of epithelial cadherin in the human male reproductive tract and gametes and evidence of its participation in fertilization. Mol Hum Reprod. 2008;14:561-71 pubmed publisher
  51. Liao H, Munoz Pinto D, Qu X, Hou Y, Grunlan M, Hahn M. Influence of hydrogel mechanical properties and mesh size on vocal fold fibroblast extracellular matrix production and phenotype. Acta Biomater. 2008;4:1161-71 pubmed publisher
  52. Rigau V, Morin M, Rousset M, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130:1942-56 pubmed
  53. Hirose T, Karasawa M, Sugitani Y, Fujisawa M, Akimoto K, Ohno S, et al. PAR3 is essential for cyst-mediated epicardial development by establishing apical cortical domains. Development. 2006;133:1389-98 pubmed